Takeda, AstraZeneca Say Indian Co. Infringed Daliresp Patent
An Indian generic drug manufacturer infringed Takeda's and AstraZeneca's patent for the chronic obstructive pulmonary disease drug Daliresp with its recent abbreviated new drug application, according to a lawsuit filed Friday...To view the full article, register now.
Already a subscriber? Click here to view full article